Biocon buys 70 pct of Germany’s AxiCorp

India’s top biotechnology firm, Biocon Ltd, has agreed to buy 70 percent of German marketing firm AxiCorp GmbH for 30 million euros ($43.7 million) to boost its business in overseas markets, Biocon said on Monday.

biocon axicorp logo

The acquisition will enable marketing and distribution of a range of pharmaceuticals including generics, biosimilars, biologics and other products in Germany and other European countries, the Indian drugmaker said.

Full article here.